Option Care Health, Inc.
A provider of home infusion therapy, delivering intravenous and injectable treatments for infections, immune disorders, and chronic illnesses directly to patients' homes. It began in 1979 when two California pharmacists, moved by a young car-accident patient who needed daily IV nutrition, pioneered bringing hospital-style infusion care into the home. The name "Option Care" was originally an acronym for "Outpatient Parenteral Therapy Intravenous Ongoing Nutrition with Care," and today's company formed in 2019 when Option Care Enterprises merged with BioScrip.
Granted 625.1K · Bought 12.5K
Granted 47.9K · Bought 188.6K
Granted 230.5K · Sold 23.2K
Granted 146.1K
Granted 14.6K · Bought 1.0K
Granted 82.1K · Bought 16.2K
Granted 27.6K · Bought 44.2K · Sold 47.2K
Granted 92.2K
Granted 9.2K
Granted 38.0K
Granted 82.8K · Sold 44.7K
Granted 19.4K · Bought 3.0K
Granted 21.5K
Granted 10.4K · Sold 47.5K
Granted 17.3K
Granted 29.7K
Granted 21.1K · Bought 3.4K
Granted 21.1K
Granted 19.4K · Bought 750 · Sold 31.8K
Granted 22.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Rademacher John CharlesChief Executive Officer, Director · 23 transactions | +159.3% | 695.2K | 625.1K | 12.5K | — |
| Kraemer Harry M Jansen JrDirector · 10 transactions | +95.7% | 459.0K | 47.9K | 188.6K | — |
| Shapiro Michael H.Chief Financial Officer · 18 transactions | +76.3% | 311.9Kas of Feb 2025 | 230.5K | — | 23.2K |
| Whitworth LukeChief Operating Officer · 20 transactions | +123.2% | 169.6K | 146.1K | — | — |
| Golding David WDirector · 4 transactions | +15.5% | 116.5Kas of Aug 2025 | 14.6K | 1.0K | — |
| Sethna MeenalChief Financial Officer · 3 transactions | — | 98.3K | 82.1K | 16.2K | — |
| Sullivan Timothy PDirector · 8 transactions | +31.3% | 82.4K | 27.6K | 44.2K | 47.2K |
| Smyser CollinGC & Corporate Secretary · 18 transactions | +310.4% | 77.5K | 92.2K | — | — |
| Arlotta JohnDirector · 1 transaction | +14.8% | 71.0Kas of May 2024 | 9.2K | — | — |
| Grashoff Christopher L.Chief Growth Officer · 16 transactions | — | 44.1K | 38.0K | — | — |
| Bavaro MichaelChief Human Resources Officer · 29 transactions | +20% | 33.2K | 82.8K | — | 44.7K |
| Bierbower Elizabeth DDirector · 4 transactions | +212.6% | 32.9K | 19.4K | 3.0K | — |
| Deckmann NatashaDirector · 5 transactions | +204.3% | 32.0K | 21.5K | — | — |
| Betten Elizabeth QuadrosDirector · 3 transactions | -56% | 29.2Kas of May 2025 | 10.4K | — | 47.5K |
| Maggio NicoleChief Accounting Officer · 12 transactions | — | 28.5K | 17.3K | — | — |
| Adewunmi FemiChief Medical Officer · 6 transactions | — | 25.3K | 29.7K | — | — |
| Wright Norman L.Director · 5 transactions | — | 24.5K | 21.1K | 3.4K | — |
| Bodem Barbara W.Director · 4 transactions | — | 21.1K | 21.1K | — | — |
| Pate R CarterDirector · 8 transactions | -80.6% | 20.6K | 19.4K | 750 | 31.8K |
| Brandt EricDirector · 4 transactions | — | 19.4K | 22.0K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: +75.2K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.